48,830
edits
Difference between revisions of "Urinary bladder metastasis"
Jump to navigation
Jump to search
Urinary bladder metastasis (view source)
Revision as of 03:59, 17 January 2017
, 03:59, 17 January 2017no edit summary
| Line 9: | Line 9: | ||
| LMDDx = [[urothelial carcinoma]] with unusual features, [[primary adenocarcinoma of the urinary bladder]], direct extension of non-bladder primary tumour in bladder (e.g. [[prostate cancer|prostate]], rectum, [[urachal carcinoma]]) | | LMDDx = [[urothelial carcinoma]] with unusual features, [[primary adenocarcinoma of the urinary bladder]], direct extension of non-bladder primary tumour in bladder (e.g. [[prostate cancer|prostate]], rectum, [[urachal carcinoma]]) | ||
| Stains = | | Stains = | ||
| IHC = [[GATA3]] -ve (commonly +ve in breast), beta-catenin +ve (nuclear staining - suggests colorectal primary), prostate markers (e.g. PSA, PSAP, NKX3.1) +ve/-ve (+ve suggests prostate primary), PAX8 +ve/-ve (+ve suggests gyne tract or RCC) | | IHC = [[GATA3]] -ve (commonly +ve in breast), beta-catenin +ve/-ve (nuclear staining - suggests colorectal primary), prostate markers (e.g. PSA, PSAP, NKX3.1) +ve/-ve (+ve suggests prostate primary), PAX8 +ve/-ve (+ve suggests gyne tract or RCC) | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||